Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study

G. Ku, G. M. Haag, H. Park, V. K. Lam, T. J. George, S. S. Kim, M. Gutierrez, V. Shankaran, S. Stein, C. S. Denlinger, E. Elimova, A. Nagrial, A. R. He, M. B. Sawyer, H. H. Yoon, R. Geva, J. Starr, G. Curigliano, T. Golan, R. von MoosR. Fritsch, D. Lim, Q. Wang, A. Patel, T. Aoyama, M. Lei, D. Greenawalt, M. Di Bartolomeo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Keyphrases